Benzinga | Oct 29, 2020 05:04AM EDT

SVB Leerink Maintains Outperform on ChemoCentryx, Raises Price Target to $84

SVB Leerink maintains ChemoCentryx (NASDAQ:CCXI) with a Outperform and raises the price target from $75 to $84.